Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia

被引:26
|
作者
Scotto, Riccardo [1 ]
Pinchera, Biagio [1 ]
Perna, Francesco [2 ]
Atripaldi, Lidia [3 ]
Giaccone, Agnese [1 ]
Sequino, Davide [2 ]
Zappulo, Emanuela [1 ]
Sardanelli, Alessia [1 ]
Schiano Moriello, Nicola [1 ]
Stanziola, Anna [2 ]
Bocchino, Marialuisa [2 ]
Gentile, Ivan [1 ,4 ]
Sanduzzi, Alessandro [2 ,4 ]
机构
[1] Univ Naples Federico II, Dept Clin Med & Surg, Infect Dis Sect, I-80131 Naples, Italy
[2] Univ Naples Federico II, Sect Resp Dis, Dept Clin Med & Surg, Monaldi Hosp, I-80131 Naples, Italy
[3] Monaldi Hosp, Lab Clin Biochem, I-80131 Naples, Italy
[4] Univ Federico II Naples, United Nations Educ Sci & Cultural Org UNESCO, Hlth Educ & Sustainable Dev, I-80131 Naples, Italy
关键词
COVID-19; SARS-CoV-2; KL-6; pneumonia; mortality; EPITHELIAL LINING FLUID; MUCIN-LIKE GLYCOPROTEIN; PROGNOSTIC VALUE; ACUTE EXACERBATION; PULMONARY; MARKER; PLASMA;
D O I
10.3390/ijerph18042078
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
KL-6 is a sialoglycoprotein antigen which proved elevated in the serum of patients with different interstitial lung diseases, especially in those with a poorer outcome. Given that interstitial pneumonia is the most common presentation of SARS-CoV2 infection, we evaluated the prognostic role of KL-6 in patients with COVID-19 pneumonia. Patients with COVID-19 pneumonia were prospectively enrolled. Blood samples were collected at the time of enrolment (TOE) and on day 7 (T1). Serum KL-6 concentrations were measured by chemiluminescence enzyme immunoassay using a KL-6 antibody kit (LUMIPULSE G1200, Fujirebio) and the cut-off value was set at >1000 U/mL. Fifteen out of 34 enrolled patients (44.1%) died. Patients with unfavourable outcome showed significantly lower P/F ratio and higher IL-6 values and plasmatic concentrations of KL-6 at TOE compared with those who survived (median KL-6: 1188 U/mL vs. 260 U/mL, p < 0.001). KL-6 > 1000 U/mL resulted independently associated with death (aOR: 11.29, p < 0.05) with a positive predictive value of 83.3%. Our results suggest that KL-6 is a reliable indicator of pulmonary function and unfavourable outcome in patients with COVID-19 pneumonia. A KL-6 value > 1000 U/mL resulted independently associated with death and showed good accuracy in predicting a poorer outcome. KL-6 may thus represent a quick, inexpensive, and sensitive parameter to stratify the risk of severe respiratory failure and death.
引用
收藏
页码:1 / 11
页数:10
相关论文
共 50 条
  • [1] KL-6 in ARDS and COVID-19 Patients
    Piazza, Ornella
    Scarpati, Giuliana
    Boccia, Giovanni
    Boffardi, Massimo
    Pagliano, Pasquale
    [J]. TRANSLATIONAL MEDICINE AT UNISA, 2022, 24 (02):
  • [2] Eosinopenia is a reliable marker of severe disease and unfavourable outcome in patients with COVID-19 pneumonia
    Cazzaniga, Massimo
    Fumagalli, Luca A. M.
    D'angelo, Luciano
    Cerino, Mario
    Bonfanti, Giulia
    Fumagalli, Riccardo M.
    Schiavo, Gianpaolo
    Lorini, Cristina
    Lainu, Elisa
    Terragni, Sabina
    Chiarelli, Marco
    Scarazzati, Claudio
    Bonato, Claudio
    Zago, Mauro
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (07)
  • [3] Serial KL-6 measurements in COVID-19 patients
    d'Alessandro, Miriana
    Bergantini, Laura
    Cameli, Paolo
    Curatola, Giuseppe
    Remediani, Lorenzo
    Bennett, David
    Bianchi, Francesco
    Perillo, Felice
    Volterrani, Luca
    Mazzei, Maria Antonietta
    Bargagli, Elena
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (06) : 1541 - 1545
  • [4] Serial KL-6 measurements in COVID-19 patients
    Miriana d’Alessandro
    Laura Bergantini
    Paolo Cameli
    Giuseppe Curatola
    Lorenzo Remediani
    David Bennett
    Francesco Bianchi
    Felice Perillo
    Luca Volterrani
    Maria Antonietta Mazzei
    Elena Bargagli
    [J]. Internal and Emergency Medicine, 2021, 16 : 1541 - 1545
  • [5] Could KL-6 levels in COVID-19 help to predict lung disease?
    AN Frix
    L. Schoneveld
    A. Ladang
    M. Henket
    B. Duysinx
    F. Vaillant
    B. Misset
    M. Moutschen
    R. Louis
    E. Cavalier
    J. Guiot
    [J]. Respiratory Research, 21
  • [6] Could KL-6 levels in COVID-19 help to predict lung disease ?
    Frix, Anne-Noelle
    Schoneveld, Lauranne
    Ladang, Aurelie
    Henket, Monique
    Duysinx, Bernard
    Vaillant, Frederique
    Misset, Benoit
    Moutschen, Michel
    Louis, Renaud
    Cavalier, Etienne
    Guiot, Julien
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [7] Could KL-6 levels in COVID-19 help to predict lung disease?
    Frix, A. N.
    Schoneveld, L.
    Ladang, A.
    Henket, M.
    Duysinx, B.
    Vaillant, F.
    Misset, B.
    Moutschen, M.
    Louis, R.
    Cavalier, E.
    Guiot, J.
    [J]. RESPIRATORY RESEARCH, 2020, 21 (01)
  • [8] Serum KL-6 concentrations as a novel biomarker of severe COVID-19
    d'Alessandro, Miriana
    Cameli, Paolo
    Refini, Rosa Metella
    Bergantini, Laura
    Alonzi, Valerio
    Lanzarone, Nicola
    Bennett, David
    Rana, Giuseppe Domenico
    Montagnani, Francesca
    Scolletta, Sabino
    Franchi, Federico
    Frediani, Bruno
    Valente, Serafina
    Mazzei, Maria Antonietta
    Bonella, Francesco
    Bargagli, Elena
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) : 2216 - 2220
  • [9] Prognostic value of serum Krebs von den Lungen-6 (KL-6) levels in COVID-19 pneumonia
    Letellier, Alice
    Rolland-Debord, Camille
    Luque-Paz, David
    Milon, Audrey
    Choinier, Pascaline
    Blin, Emmanuelle
    Halitim, Pierre
    Bravais, Juliette
    Lefevre, Guillaume
    Parrot, Antoine
    Pieroni, Laurence
    Cadranel, Jacques
    [J]. RESPIRATORY MEDICINE AND RESEARCH, 2023, 84
  • [10] Serum KL-6 as a Candidate Predictor of Outcome in Patients with SARS-CoV-2 Pneumonia
    Kattner, Simone
    Sutharsan, Sivagurunathan
    Berger, Marc Moritz
    Limmer, Andreas
    Jehn, Lutz-Bernhard
    Herbstreit, Frank
    Brenner, Thorsten
    Taube, Christian
    Bonella, Francesco
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (21)